A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart FailureNovelty and Significance

Title
A Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells in Patients With Ischemic or Nonischemic Heart FailureNovelty and Significance
Authors
Keywords
-
Journal
CIRCULATION RESEARCH
Volume 117, Issue 6, Pages 576-584
Publisher
Ovid Technologies (Wolters Kluwer Health)
Online
2015-07-07
DOI
10.1161/circresaha.115.306332

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More